| Anoikis and EMT: lethal" liaisons" during cancer progression Z Cao, T Livas, N Kyprianou Critical Reviews™ in Oncogenesis 21 (3-4), 2016 | 172 | 2016 |
| Mechanisms navigating the TGF-β pathway in prostate cancer Z Cao, N Kyprianou Asian journal of urology 2 (1), 11-18, 2015 | 86 | 2015 |
| Multinucleation and mesenchymal-to-epithelial transition alleviate resistance to combined cabazitaxel and antiandrogen therapy in advanced prostate cancer SK Martin, H Pu, JC Penticuff, Z Cao, C Horbinski, N Kyprianou Cancer research 76 (4), 912-926, 2016 | 78 | 2016 |
| Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells Z Cao, S Koochekpour, SE Strup, N Kyprianou Oncotarget 8 (45), 78507, 2017 | 22 | 2017 |
| Predictive and targeting value of IGFBP-3 in therapeutically resistant prostate cancer PJ Hensley, Z Cao, H Pu, H Dicken, D He, Z Zhou, C Wang, ... American Journal of Clinical and Experimental Urology 7 (3), 188, 2019 | 14 | 2019 |
| PD14-02 OVERCOMING RESISTANCE TO ANTIANDROGENS VIA TARGETING IGBP3 IN PROSTATE CANCER P Hensley, Z Cao, S Koochekpoor, N Kyprianou The Journal of Urology 199 (4S), e304-e305, 2018 | | 2018 |
| Pharmacologic interconversion of EMT to MET for prostate cancer Z Cao, S Koochekpour, SE Strup, N Kyprianou Cancer Research 77 (13_Supplement), 2122-2122, 2017 | | 2017 |
| PD33-03 PHARMACOLOGIC TARGETING OF TGF-β MEDIATED EMT IN PROSTATE CANCER Z Cao, S Koochekpour, S Strup, N Kyprianou The Journal of Urology 197 (4S), e594-e594, 2017 | | 2017 |
| Cabazitaxel chemotherapy targets mitotic kinesins resulting in multi-nucleation of prostate cancer cells: A novel mechanism of cross-resistance with antiandrogens in advanced CRPC SK Martin, H Pu, C Horbinski, Z Cao, N Kyprianou Cancer Research 75 (15_Supplement), 2567-2567, 2015 | | 2015 |
| WITHDRAWN: Mechanisms navigating the TGF-β pathway in prostate cancer Z Cao, N Kyprianou Asian Journal of Urology, 2014 | | 2014 |
